PDHB and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), CRISPR/Cas9 knockout library screening revealed the crucial role of pyruvate metabolism in HCC treatment, particularly when combined with a glutamine-deficient diet, showing the targetable metabolic vulnerabilities of pyruvate dehydrogenase α(PDHA), pyruvate dehydrogenase β(PDHB), and pyruvate carboxylase (PC) [128].